← Leaderboards
Ophir Shalem
Children'S Hosp Of Philadelphia
$3,915,331
Attributed
$5,528,594
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,528,594 · 4
By mechanism
DP2$2,796,648 · 1
R01$2,379,946 · 2
R03$352,000 · 1
Top collaborators
- Ronen Marmorstein2 shared
- Ernest James Petersson2 shared
- Elizabeth Rhoades2 shared
- Michael Gandal1 shared
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Struan F A Grant$26,708,768
- Matthew Jolley$3,710,326
- Wensi Wu$436,901
- Allison Heath$10,021,307
- Ramakrishnan Rajagopalan$890,000
Others in their field
Other Emerging Leaders on “Biological”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$377,088,269
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$343,713,561
- Chanza Baytop · Westat, Inc.$271,217,917
- Lynn Briscoe · Leidos Biomedical Research, Inc.$149,803,496
Research focus
BiologicalCellsGenesScreeningAlzheimer&AposProteinsAffectBindingGenome-WideSmall MoleculeNeuronsGeneticInsightMolecularImageHuman Cell LineInduced Pluripotent Stem Cell Derived Human NeuronGenome Wide ScreenHigh Throughput ScreeningInduced Pluripotent Stem Cell Derived NeuronsAcuteFluorescenceCell LineDisorder Risk
Grant awards (6)
Role of N-terminal acetylation in alpha synuclein stability, function, and therapeutic targeting in synucleinopathies$834,688
R01 · FY2025 · NS
Cellular and developmental genetic regulation of 3' isoform diversity in the human brain and its contribution to neuropsychiatric disorders$686,787
R01 · FY2025 · MH
Role of N-terminal acetylation in alpha synuclein stability, function, and therapeutic targeting in synucleinopathies$858,471
R01 · FY2024 · NS
Administrative Supplement for Direct and rapid control of proteins at scale$156,648
DP2 · FY2022 · GM · contact PI
Direct and rapid control of proteins at scale$2,640,000
DP2 · FY2019 · GM · contact PI
Dissecting the mechanisms that underlie mislocalization and aggregation of RNA binding proteins in neurodegenerative diseases$352,000
R03 · FY2019 · NS · contact PI